As the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, Fulling will be accountable for the overall strategy, organizational leadership, financial performance, and next-level growth of this market-leading commercial enterprise.

Dentsu today announced the appointment of Eduardo Tavares as Executive Creative Director, dentsu health. In this role, multi-award winner Tavares, will concept and deliver best-in-class creative campaigns – merging data and technology with craft – to drive value and competitive advantage for dentsu health clients across health & wellness and pharmaceutical sectors. 

Price brings more than 25 years of experience in pharmaceutical marketing, extensive expertise across a wealth of therapy areas, and deep leadership experience in the EMEA and APAC regions.

Global healthcare communications company SCIRIS is delighted to announce the appointment of Isaac Batley as new CEO.

Chris Ozanian will be responsible for expanding on JUICE’S ongoing digital success with clients who are craving omnichannel leadership and a customer-focused approach to digital marketing.

Ylagan joins the agency’s creative leadership team and will oversee a NY-based and hybrid team of art directors, playing a crucial role in producing the visual communications for his brands and in growing a culture of artistic inventiveness.

The privately-held, full-service global creative marketing communications agency focused on healthcare has appointed Katya Petrova to chief business officer with the responsibility of providing JUICE clients with direction and oversight from inception through execution.

Berman will oversee the creative across all clients, building on the agency’s creative reputation and advancing its mission of creating inspiring ideas that emotionally move people to take action.

Visconti will oversee all aspects of the agency’s marketing intelligence services, leading a team of accomplished specialists who provide data, analysis, insights, multi-touch attribution models, predictive data intelligence, and success metrics for enhancing client and agency decision-making and optimizing the impact of client marketing campaigns.

Capping a tumultuous year of legal battles, Teva Pharmaceuticals has found a new president and CEO. Effective Jan. 1, 2023, Richard Francis will take the company’s reins as Kåre Schultz retires.